Recent studies have shown that DK7 (THZ1) inhibitors can inhibit the expression of p38 and induce tumor shrinkage; however, the use of the combination of THZ1 and LY2228820 has a synergistic effect on inhibiting the proliferation of cancer cells. Here, MAPK1 is linked to cancer.